BNP Paribas Financial Markets
MBOT icon

BNP Paribas Financial Markets’s Microbot Medical MBOT Stock Holding History

BNP Paribas Financial Markets’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
+69,717
New +$156K ﹤0.01% 4130

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BNP Paribas Financial Markets's MBOT Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Microbot Medical (MBOT) in Q1 2026: 69,717 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #4130 among its holdings.

79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • BNP Paribas Financial Markets held 69,717 shares of Microbot Medical worth $168K as of Q1 2026.
  • Microbot Medical was a new BNP Paribas Financial Markets position in Q1 2026.
  • Microbot Medical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4130 holding.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.